Navigation Links
PDI Reports 2014 Second Quarter Financial Results
Date:8/13/2014

ments in our strategic initiatives. Factoring in the Asuragen acquisition and anticipated additional spending in Interpace Diagnostics, the company estimates year end 2014 cash of $22 - $25 million.

As of June 30, 2014, the company's cash equivalents were predominantly invested in U.S. Treasury money market funds and the company had no commercial debt.

Non-GAAP Financial MeasuresIn addition to the United States generally accepted accounting principles, or GAAP, results provided throughout this document, PDI has provided a certain non-GAAP financial measure to help evaluate the results of its performance. The company believes that this non-GAAP financial measure, when presented in conjunction with comparable GAAP financial measure, is useful to both management and investors in analyzing the company's ongoing business and operating performance. The company believes that providing non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the company's financial results in the way that management views financial results.

In this document, the company discusses Adjusted EBITDA, a non-GAAP financial measure. Adjusted EBITDA is a metric used by management to measure cash flow of the ongoing business. Adjusted EBITDA is defined as operating income or loss, plus depreciation and amortization, non-cash stock-based compensation, and other non-cash expenses. The table below includes a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure.

 Adjusted EBITDA (Unaudited)($ in thousands)2nd Quarter EndedSix Months EndedJune 30,June 30,2014201320142013Operating (loss) income 

$
(2,523)
$
(847)
$
(4,020)
'/>"/>

SOURCE PDI, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
2. Organovo Highlights Liver Toxicology Achievement, Reports Q1 Fiscal 2015 Results
3. Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update
4. Aratana Therapeutics Reports Second Quarter 2014 Results
5. Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014
6. Halozyme Reports Second Quarter 2014 Financial Results
7. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
8. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
9. Omeros Corporation Reports Second Quarter 2014 Financial Results
10. Darling Ingredients Inc. Reports Commencement Of Exchange Offer For 5.375% Senior Notes Due 2022
11. Soligenix Reports Second Quarter 2014 Financial Results, and Highlights Recent Accomplishments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... , Nov. 23, 2014 Anthera Pharmaceuticals, ... Paul F. Truex , President and Chief Executive ... Annual Piper Jaffray Healthcare Conference. Anthera ... at the Palace Hotel in New York ... Anthera Pharmaceuticals is a biopharmaceutical company focused ...
(Date:11/22/2014)... -- Sprout Pharmaceuticals today announced positive preliminary results from a Phase ... up to 200 mg at bedtime had no next-day impairment ... th Annual Fall Scientific Meeting of the Sexual Medicine ... Miami . The Phase 1 driving ... and the Formal Dispute Resolution that was filed in December ...
(Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 2Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment 3CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4
... 29, 2011 Breast cancer patients and their families ... (FDA) decision to remove the anti-cancer drug Avastin from ... breast cancer. Terry Kalley, founder of the ... the decision, saying, "While this vote is disappointing, it ...
... Mass., June 29, 2011 NxStage® Medical, Inc. (Nasdaq: ... dialysis products, announced that it has entered into a ... move its corporate headquarters to the revitalized historic mill ... Street, Lawrence, MA.  The move, which is expected to ...
Cached Medicine Technology:Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List 2NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA 2
(Date:11/26/2014)... (HealthDay News) -- Teens prescribed anti-anxiety or sleep ... drugs than other teens, a new study warns. ... substance abuse assessments on teenagers before prescribing these ... and parents don,t realize the abuse potential," said ... University of Michigan School of Nursing. "These drugs ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, ... Nexium may disrupt the makeup of bacteria in the digestive ... a small new study suggests. The research doesn,t ... become ill, and study authors aren,t recommending that anyone stop ... "should be used at the lowest dose that provides adequate ...
(Date:11/24/2014)... November 24, 2014 The Healthy Skin ... reviews of affordable skin care products, recently announced its ... offers readers a wide variety of articles, tips, and ... as organic skincare alternatives. , According to Emily Lataille, ... main content includes thoroughly researched reviews, tips for the ...
(Date:11/24/2014)... 2014 Abington Health is ... has joined The Neurology Group and has been named ... , A graduate of Vinnica Medical University in ... Einstein Medical Center in Philadelphia and completed a fellowship ... Center at Weill Cornell Medical College. Ternopolska is board ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 Recently, SweetDressy.com, ... industry, unveiled its new collection of 2014 Evening Dresses. ... now. According to the company’s marketing manager, the special ... http://www.sweetdressy.com/evening-dresses.html for more. , Sweetdressy.com has been working ... pleased to unveil the latest designs. Their new dresses ...
Breaking Medicine News(10 mins):Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2
... (October 28, 2010) University of Minnesota Medical School ... a correlation between increased circuit activity in the right ... triggered by post traumatic stress disorder (PTSD). The ... neural activity, its impact and its manifestation is the ...
... News) -- Improving mothers, literacy skills may boost the ... study. U.S. researchers concluded that a mother,s reading ... critical factor influencing her children,s future academic success, even ... neighborhood income. For their study, the researchers examined ...
... American Academy of Pediatrics (AAP) recommends that parents limit combined ... 2 hours per day for preschool-age children. In a ... Pediatrics , researchers found that many children are exposed to ... with 66% exceeding the recommended daily amount. According to ...
... opinion polls, including newly released data, shows that those who ... in 2010 and those who say they intend to vote ... of what they want the future of health reform legislation ... in Congress on this issue. Nearly three-fourths (73%) ...
... Oct. 27 (HealthDay News) -- When it comes to feelings, ... People tend to have worse and more intense views on ... that have already taken place. The observation touches upon ... people apparently take more extreme positions regarding events that have ...
... evolution in action in cancer cells. They show the ... only is cancer genetically different between different patients, but ... has acquired distinct mutations. Effectively, ten different ... tumours. The complexity of pancreatic cancer genetics uncovered in ...
Cached Medicine News:Health News:U of M researchers identify possible key to treating, understanding post-traumatic stress disorder 2Health News:Moms' Literacy Pivotal to Kids' Academic Success 2Health News:New study suggests most preschool-age children exceed daily screen time recommendations 2Health News:Prospective voters and the new health care law 2Health News: Future Seems to Be Viewed More Harshly Than Past 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 3
Ferris Smith Rongeurs, 12 overall length 300 mm....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... It is designed for ... the surgeon greater freedom in ... 3-point rigid skeletal fixation is ... lateral, or sitting positions. Craniotomies ...
Medicine Products: